Sickle cell screening kit for Frimley Health comes from OptiGene
- Frimley Health NHS Foundation Trust
- South East
- Call-off from a framework agreement
- 1 July 2026 to 31 March 2027
Frimley Health NHS Foundation Trust is buying sickle cell screening supplies from OptiGene Limited for the Berkshire and Surrey Pathology Services (BSPS) network.
OptiGene provides the reagents and other consumables the network's screening service runs on, and maintains the equipment.
The trust ordered through a framework agreement in June 2026. The £345,055 contract runs to March 2027.
Contract ends March 2027
- What
- Pathology managed services and blood sciences analysers
- Supplier
- OptiGene Limited
- Value
- £345,055
- How it was bought
- Call-off from a framework agreement
- Dates and next
- Jul 2026 to Mar 2027